Drug Platform: GEMINI

Gemini is a proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD®) that reduces the damage associated with inflammation by reprogramming the innate immune system to respond to stress (trauma, infection, etc.) in an attenuated manner.

Lead Drug: GEM-AKI

GEM-AKI is designed to help the body’s own immune system calm the harmful inflammation that can damage the kidneys during acute kidney injury (AKI). GEM-AKI is given intravenously (by IV) to patients with moderate to severe AKI, a sudden and dangerous loss of kidney function that often happens during a hospital stay. Having completed early clinical studies, GEM-AKI is now advancing into later-stage development.

Learn More >